The Role of Ergosterol and Sphingolipids in the Localization and Activity of Candida albicans’ Multidrug Transporter Cdr1p and Plasma Membrane ATPase Pma1p

Opportunistic pathogen Candida albicans causes systemic infections named candidiasis. Due to the increasing number of multi-drug resistant clinical isolates of Candida sp., currently employed antifungals (e.g., azoles) are insufficient for combating fungal infection. One of the resistance mechanisms toward azoles is increased expression of plasma membrane (PM) transporters (e.g., Cdr1p), and such an effect was observed in C. albicans clinical isolates. At the same time, it has been proven that a decrease in PMs sphingolipids (SLs) content correlates with altered sensitivity to azoles and diminished Cdr1p levels. This indicates an important role for SL in maintaining the properties of PM and gaining resistance to antifungal agents. Here, we prove using a novel spot variation fluorescence correlation spectroscopy (svFCS) technique that CaCdr1p localizes in detergent resistant microdomains (DRMs). Immunoblot analysis confirmed the localization of CaCdr1p in DRMs fraction in both the C. albicans WT and erg11Δ/Δ strains after 14 and 24 h of culture. We also show that the C. albicans erg11Δ/Δ strain is more sensitive to the inhibitor of SLs synthesis; aureobasidin A (AbA). AbA treatment leads to a diminished amount of SLs in C. albicans WT and erg11Δ/Δ PM, while, for C. albicans erg11Δ/Δ, the general levels of mannose-inositol-P-ceramide and inositol-P-ceramide are significantly lower than for the C. albicans WT strain. Simultaneously, the level of ergosterol in the C. albicans WT strain after adding of AbA remains unchanged, compared to the control conditions. Analysis of PM permeabilization revealed that treatment with AbA correlates with the disruption of PM integrity in C. albicans erg11Δ/Δ but not in the C. albicans WT strain. Additionally, in the C. albicans WT strain, we observed lower activity of H+-ATPase, correlated with the delocalization of both CaCdr1p and CaPma1p.


Introduction
Candida albicans constitutes a part of the normal microbiota of healthy individuals [1]. In case of immunodeficiency (e.g., HIV infection) C. albicans can lead to life-threatening systemic infections (candidiasis). A limited number of clinically employed antifungal therapeutics translates into increasing resistance of Candida sp. [2]. Azoles (e.g., fluconazole and miconazole), one of the most commonly used antifungals, targets the enzyme Erg11p (encoded by the ERG11 gene), which is responsible for the removal of the C-14α-methyl group from lanosterol in ergosterol biosynthesis pathway [3]. The disruption of biosynthesis corresponds to the diminished plasma membrane (PM) ergosterol content and pathogen growth inhibition. On the other hand, decades of azole usage led to the formation of multiple resistance strategies of C. albicans. These include the upregulated expression of ERG11 (via point mutation in UPC2, a transcription factor for ERG11 gene, or in ERG11 directly) and genes encoding C. albicans drug resistance transporters (e.g., CDR1, CDR2, and MDR1) [4]. Efflux pumps, Candida drug resistance protein 1 and 2 (CaCdr1p and CaCdr2p, respectively), belong to the ABC transporters family and azoles are substrates for these proteins. Furthermore, the overexpression of CDR1 and CDR2 was detected in azole-resistant oral and vaginal C. albicans clinical isolates [2,5].
Still, not all of the drug resistance strategies of C. albicans are fully understood. Interestingly, it has been proven that the inhibition of the mannose-(inositol phosphate)2-ceramide (M(IP) 2 C) biosynthesis, a sphingolipid (SL) present in C. albicans PM, correlates with significantly elevated susceptibility to azoles [6]. In addition, the deletion of the IPT1 gene (encoding inositol phosphotransferase required for biosynthesis of M(IP) 2 C) in C. albicans resulted in a decreased level of Cdr1p in fungal PM [7]. This suggests that SLs play a significant role in maintaining the PM structure and proper functioning of multidrug resistance transporters. Thus, it is relevant to further investigate the importance of SLs in CaCdr1p activity. SLs participate in the creation of ordered domains, as well as the segregation of fungal PM components [8]; however, SL-enriched domains (SLEDs) were extensively studied only in Saccharomyces cerevisiae model organisms [9].
Here, we demonstrate that Cdr1p localizes in the lipid rafts of both the C. albicans WT and ergosterol deficient (erg11∆/∆) strains using a novel spot variation fluorescence correlation spectroscopy (svFCS) technique [10], which was confirmed by the analysis using Optiprep tm and Western Blot. CaCdr1p was found in the same fractions as plasma membrane H + -ATPase (CaPma1p-GFP), which naturally concentrate in the detergentresistant microdomains (DRMs) of S. cerevisiae and have been used as a marker for DRMs in other fungi [11,12]. Following the treatment of C. albicans strains by aureobasidin A (AbA), a cyclic depsipeptide that inhibits the activity of the catalytic subunit of IPC synthase (Aur1) [13], we observed a significant decrease in both the IPC and MIPC levels in PM.
Disruption of the PM structure (lipid rafts) resulted in the delocalization of CaCdr1p and CaPma1p from PM to the inside of cells, permeabilization of PM, and a decrease in the activity of the studied proteins.
To our knowledge, here, for the first time in the literature, we show results indicating that both ergosterol and SLs are crucial for the maintenance of C. albicans' PM structure. Moreover, ergosterol partially compensate for the lack of SLs in C. albicans' PM.
The obtained data open new paths for further research on the role of SLs in Candida sp. resistance to antifungals involving multidrug transporters, which will provide a better understanding of those mechanisms and contribute to the development of new antifungal therapies.

CaCdr1p Is Located in Nanodomains of PM of C. albicans
Some disruptive (by use of detergents, sequesters, or genetic approaches) and nondisruptive (e.g., fluorescence correlation spectroscopy (FCS) or fluorescence resonance energy transfer (FRET)) techniques are already used for the structure and function of lipid domains study. It has recently been proven that the svFCS can be used for the detailed examination of the molecular dynamics of plasma membrane lateral organization in living cells [10].
The offset t0 depends on membrane properties, such as lipid composition and actin cytoskeleton organization, which allows for a biological insight into the origin of the observed phenomenon [10,14,15].
The svFCS method enables space-time analysis of labeled single molecules in the cell membrane. The law of diffusion established by the svFCS allows for determining the diffusion times of individual membrane components and the nature of their movement in the plasma membrane. The diffusion time depends on the size of the molecule. The larger the molecule, the longer the diffusion time. The nature of diffusion depends on intermolecular interactions. In the absence of interactions, the free diffusion characteristic of the Brownian motion is observed. In such diffusion, the point of intersection with the 0Y (t0 value) is close to 0. In the case of interactions, for example, the molecule's location in the nanodomain is greater than zero [16].
Cdr1p-GFP in both C. albicans strains (CAF2-1-70 ms and erg11∆/∆-65 ms) has a positive t0 value ( Figure 1A,B), indicating the localization of this transporter in the PM nanodomains. The high t0 value also reflects the relatively high labeled Cdr1p-GFP protein size. In the case of the C. albicans erg11∆/∆ strain, the t0 value is about 5 ms lower than in the CAF2-1 strain. This slight decrease may suggest that Cdr1p-GFP membrane diffusion was changed into a more Brownian, free diffusion mode. This result indicates that the lack of ergosterol does not destroy nanodomains. We could hypothesize that lack of the ergosterol could be somehow compensated in the nanodomains by SLs, resulting in only a small difference in the diffusion properties of Cdr1p-GFP. the plasma membrane. The diffusion time depends on the size of the molecule. The larger the molecule, the longer the diffusion time. The nature of diffusion depends on intermolecular interactions. In the absence of interactions, the free diffusion characteristic of the Brownian motion is observed. In such diffusion, the point of intersection with the 0Y (t0 value) is close to 0. In the case of interactions, for example, the molecule's location in the nanodomain is greater than zero [16].
Cdr1p-GFP in both C. albicans strains (CAF2-1-70 ms and erg11∆/∆-65 ms) has a positive t0 value ( Figure 1A,B), indicating the localization of this transporter in the PM nanodomains. The high t0 value also reflects the relatively high labeled Cdr1p-GFP protein size. In the case of the C. albicans erg11∆/∆ strain, the t0 value is about 5 ms lower than in the CAF2-1 strain. This slight decrease may suggest that Cdr1p-GFP membrane diffusion was changed into a more Brownian, free diffusion mode. This result indicates that the lack of ergosterol does not destroy nanodomains. We could hypothesize that lack of the ergosterol could be somehow compensated in the nanodomains by SLs, resulting in only a small difference in the diffusion properties of Cdr1p-GFP. Although the svFCS method seems suitable for analyzing the localization of CaCdr1p in lipid nanodomains, it is good to use an alternative method to make the results more plausible. For this purpose, we obtained fractions of the PM, and then we visualized the localization of CaCdr1p and CaPma1p in individual fractions by Western Blot using rabbit anti-GFP serum ( Figure 2).
As described previously [17,18], DRM usually constitutes the upper two fractions when the equal six fractions from top to bottom are taken. Pasrija et al. [18] used 30% Optiprep tm in their study. Pma1p was previously localized in the PM microdomains of S. cerevisiae by Bagnat et al. [12]; hence, it can be considered an indicator of the localization of other membrane proteins, e.g., Cdr1p.
Our immunoblot analysis indicated the presence of both CaPma1p-GFP and CaCdr1p-GFP, mainly in two floating top fractions of 30% Optiprep tm ( Figure 2B) in the case CAF2-1 strain in 8, 14, and 24 h of culture. We used the division into three fractions in the 30% gradient of Optiprep tm and observed the presence of Pma1p in the third fraction in all culture times. Cdr1p appeared in the third fraction only at 24h of the C. albicans culture ( Figure 2B, left panel). In the case of a mutant without ergosterol (erg11∆/∆), Pma1p-GFP was present in three fractions of 30% Optiprep tm . However, in the early phase of growth (8 h), C. albicans Pma1p occurs in DRM at a low level ( Figure 2B, right panel).
We did not detect the presence of Cdr1p in DRM in the early growth phase (8 h) of erg11∆/∆ C. albicans. Cdr1p was localized in DRM at 14 h growth of this strain. In the late Although the svFCS method seems suitable for analyzing the localization of CaCdr1p in lipid nanodomains, it is good to use an alternative method to make the results more plausible. For this purpose, we obtained fractions of the PM, and then we visualized the localization of CaCdr1p and CaPma1p in individual fractions by Western Blot using rabbit anti-GFP serum ( Figure 2).
As described previously [17,18], DRM usually constitutes the upper two fractions when the equal six fractions from top to bottom are taken. Pasrija et al. [18] used 30% Optiprep tm in their study. Pma1p was previously localized in the PM microdomains of S. cerevisiae by Bagnat et al. [12]; hence, it can be considered an indicator of the localization of other membrane proteins, e.g., Cdr1p.
Our immunoblot analysis indicated the presence of both CaPma1p-GFP and CaCdr1p-GFP, mainly in two floating top fractions of 30% Optiprep tm ( Figure 2B) in the case CAF2-1 strain in 8, 14, and 24 h of culture. We used the division into three fractions in the 30% gradient of Optiprep tm and observed the presence of Pma1p in the third fraction in all culture times. Cdr1p appeared in the third fraction only at 24h of the C. albicans culture ( Figure 2B, left panel). In the case of a mutant without ergosterol (erg11∆/∆), Pma1p-GFP was present in three fractions of 30% Optiprep tm . However, in the early phase of growth (8 h), C. albicans Pma1p occurs in DRM at a low level ( Figure 2B, right panel). culturing), indicated that the most of the Pma1p localizes in the fraction containing 30% of Optiprep tm (Supplementary Figure S2A). Ponceau S staining reveals accumulation of the most of isolated proteins onto top on the gradient, which, along with similar localization of Pma1p, confirms efficient isolation of proteins associated with DRMs (Supplementary, Figure S2A). Cdr1p localizes together with Pma1p, suggesting its accumulation in DRMs (Supplementary, Figure S2B). Wild-type CAF2-1 and ergosterol-deficient erg11∆/∆ strains were cultured for 8, 14, and 24 h in a YPD medium. Whole-cell extracts were obtained by glass-beads cell disruption, as described in Materials and Methods. Samples were subjected to Optiprep tm gradient (fractions with 0%, 5%, 30% and 40%), followed by ultracentrifugation (35,000 rpm, 17 h). Collected fractions were applied on SDS-PAGE and analyzed by western blot with anti-Cdr1 and anti-GFP antibodies.

Low Sphingolipid Level in the PM Strongly Inhibits the Growth of C. albicans Mutant without Ergosterol (erg11∆/∆)
Bagnat et al. [12] found that both sphingolipids and ergosterol, which are constituents of DRMs, may be necessary for the proper localization of the Cdr1 protein in PM. They also observed that the deletion of genes encoding enzymes for ergosterol biosynthesis and sphingolipid pathways leads to the mislocation of Cdr1p, as well as its decreased We did not detect the presence of Cdr1p in DRM in the early growth phase (8 h) of erg11∆/∆ C. albicans. Cdr1p was localized in DRM at 14 h growth of this strain. In the late (24 h) phase of the growth of the erg11∆/∆ strain, we observed a much smaller level of Cdr1p than in 14 h growth, as well as compared to the level of Pma1p after 24 h of mutant culture without ergosterol ( Figure 2B, right panel). The results shown in the immunoblot correlate with the results obtained with svFCS. In both methods, it was shown that, in the erg11∆/∆ mutant, after 24 h of culture, there is less Cdr1p in the nanodomains/DRM than in the WT strain. In addition, in WT, the Cdr1 protein is present in a larger amount of fraction than in the erg11∆/∆ strain, which may indicate that, as a result of the changes in membrane diffusion, part of the protein has been delocalized from the membrane.
The preliminary test, with an example of the protein content in the fractions collected from the DRM isolation procedure with Optiprep tm gradient (erg11∆/∆ strain, 24 h of culturing), indicated that the most of the Pma1p localizes in the fraction containing 30% of Optiprep tm (Supplementary Figure S2A). Ponceau S staining reveals accumulation of the most of isolated proteins onto top on the gradient, which, along with similar localization of Pma1p, confirms efficient isolation of proteins associated with DRMs (Supplementary, Figure S2A). Cdr1p localizes together with Pma1p, suggesting its accumulation in DRMs (Supplementary, Figure S2B).

Low Sphingolipid Level in the PM Strongly Inhibits the Growth of C. albicans Mutant without Ergosterol (erg11∆/∆)
Bagnat et al. [12] found that both sphingolipids and ergosterol, which are constituents of DRMs, may be necessary for the proper localization of the Cdr1 protein in PM. They also observed that the deletion of genes encoding enzymes for ergosterol biosynthesis and sphingolipid pathways leads to the mislocation of Cdr1p, as well as its decreased activity. The above study was conducted on non-pathogenic yeast S. cerevisiae containing genes from C. albicans. To the best of our knowledge, there is a lack of information on the effect of the lipid composition in DRMs on Cdr1p directly in pathogenic C. albicans fungi, so we decided to conduct appropriate research.
Previously, our results showed frail growth of the mutant C. albicans without ergosterol (erg11∆/∆), in comparison to the WT strain (CAF2-1), when grown in complex YPD under aerobic conditions [19]. Mukhopadhyay et al. [7] found that the C. albicans mutants, with deletions of the ERG6 and ERG16 genes of the ergosterol biosynthesis pathway, are supersensitive to many drugs, including 4-nitroquinoline, oxide, terbinafine, and ophenanthroline, as well as to itraconazole and ketoconazole. Our results indicated that the deletion of the ERG11 gene encoding the lanosterol demethylase, which is a target for azoles, causes a loss of sensitivity of C. albicans to azoles [19] and hypersensitivity to compounds such as capric acid [20] or surfactin [21].
Results presented in Figure 3 indicate high lethality of the ergosterol-free C. albicans strain (erg11∆/∆), under the influence of aureobasidin A (AbA). AbA is an inhibitor of the synthesis of inositol-P-ceramide (IPC), sphingolipid, which is a constituent of PM and precursor of other PM sphingolipids. At a concentration of 0.0031 µg/mL of AbA, the erg11∆/∆ strain is almost one and a half orders more sensitive than the CAF2-1 strain ( Figure 3B). Minimal inhibitory concentrations of 50 and 90 (MIC50 and 90) for mutant erg11∆/∆ were estimated at 0.007 and 0.01 µg/mL and 7-and 10-fold lower than for WT strain, respectively ( Figure 3A). activity. The above study was conducted on non-pathogenic yeast S. cerevisiae containing genes from C. albicans. To the best of our knowledge, there is a lack of information on the effect of the lipid composition in DRMs on Cdr1p directly in pathogenic C. albicans fungi, so we decided to conduct appropriate research. Previously, our results showed frail growth of the mutant C. albicans without ergosterol (erg11∆/∆), in comparison to the WT strain (CAF2-1), when grown in complex YPD under aerobic conditions [19]. Mukhopadhyay et al. [7] found that the C. albicans mutants, with deletions of the ERG6 and ERG16 genes of the ergosterol biosynthesis pathway, are supersensitive to many drugs, including 4-nitroquinoline, oxide, terbinafine, and o-phenanthroline, as well as to itraconazole and ketoconazole. Our results indicated that the deletion of the ERG11 gene encoding the lanosterol demethylase, which is a target for azoles, causes a loss of sensitivity of C. albicans to azoles [19] and hypersensitivity to compounds such as capric acid [20] or surfactin [21].
Results presented in Figure 3 indicate high lethality of the ergosterol-free C. albicans strain (erg11∆/∆), under the influence of aureobasidin A (AbA). AbA is an inhibitor of the synthesis of inositol-P-ceramide (IPC), sphingolipid, which is a constituent of PM and precursor of other PM sphingolipids. At a concentration of 0.0031 μg/mL of AbA, the erg11∆/∆ strain is almost one and a half orders more sensitive than the CAF2-1 strain (Figure 3B). Minimal inhibitory concentrations of 50 and 90 (MIC50 and 90) for mutant erg11∆/∆ were estimated at 0.007 and 0.01 μg/mL and 7-and 10-fold lower than for WT strain, respectively ( Figure 3A).

Aureobasidin a Changes the Lipid Composition in PM of C. albicans
The loss of ergosterol results in the destabilization of PM, its decreased permeability, reduced fluidity, and decreased potential (∆ψ) [19]. In addition to ergosterol, the second component of C. albicans DRM are sphingolipids (SLs), which structurally differ from those in mammalian cells [7]. Hypothetically SLs structures are synthesized by cells to compensate for the loss of ergosterol in the membrane by matching in terms of polarity. In S. cerevisiae, it was observed that mutants deprived of the genes involved in ergosterol synthesis increased SLs synthesis with smaller polar head groups (e.g., mannose-inositol-P-ceramide and inositol-P-ceramide (MIPC + IPC)) and decreased SLs synthesis with the largest polar head group (mannose-(inositol-P) 2 -ceramide (M(IP) 2 C)) [22].
Therefore, we were interested in investigating the individual SL classes in C. albicans. We checked the presence and concentration of IPC, MIPC, and M(IP) 2 C in the C. albicans CAF2-1 (WT strain) and mutant without ergosterol KS028 (erg11∆/∆) during treatment with and without AbA.
In the CAF2-1, the ergosterol level increases in the logarithmic phase of growth and decreases in the stationary phase. These data are consistent with our earlier results [19], and a similar effect was observed in cases of other fungi [23]. Thus, it can be assumed that such an effect is universal. In the CAF2-1 strain, the ergosterol level slightly decreased after AbA treatment ( Figure 4A). The concentration of both IPC and MIPC decreased with the ageing of the CAF2-1 culture. In all tested phases of the growth of C. albicans CAF2-1, the level of IPC and MIPC significantly decreased ( Figure 4B). On the other hand, in the KS028 strain, the decrease in the level of IPC during the ageing of the culture was not observed. However, the amount of MIPC was dropped ( Figure 4B). The addition of AbA strongly reduced the level of IPC and MIPC in all phases of KS028 growth ( Figure 4B). After 8 and 14 h of cultivation, KS028 had about 50% less IPC in PM than CAF2-1. In the stationary growth phase, the KS028 strain had about 15% less IPC than the WT strain. The differences in the MIPC levels in both studied strains were much smaller than in IPC ( Figure 4B). We did not find M(IP) 2 C in the tested samples.  Analysis of the molecular species of sphingolipids revealed nine species of IPC and MIPC in samples (Supplementary Materials, Figure S1). These species are represented as the "total number of carbons in the sphingoid backbone and the fatty acyls:total number of double bonds;total number of hydroxyl groups in the sphingoid backbone and the fatty acyls" [24]. Among   Analysis of the molecular species of sphingolipids revealed nine species of IPC and MIPC in samples (Supplementary Materials, Figure S1). These species are represented as the "total number of carbons in the sphingoid backbone and the fatty acyls:total number of double bonds;total number of hydroxyl groups in the sphingoid backbone and the fatty acyls" [24]. Among them, in all samples, IPC 42:0;4 and MIPC 42:0;4 dominated. There was a shift in the molecular species of both IPC and MIPC in C. albicans CAF2-1 older cultures. At 24 h, compared to 8 h, the ratio of longer-chain (such as 44:0;4) to shorter chain species (such as 42:0;4) was higher. Such phenomenon was not so clearly visible in KS028 (erg11∆/∆). In our previous studies, we observed the delocalization of CaPma1p and CaCdr1p, from PM to vacuole, after 8 h of the culture of the strain without ergosterol, unlike the WT strain, in which such delocalization took place only after 14 h of culture [19].
In this work, we present results from the localization of Pma1p-GFP and Cdr1p-GFP in strains C. albicans WT (YHXW11 and AsCa1) and erg11∆/∆ (KS045 and KS023), as well as in the presence of AbA, with a reduced level of SLs (IPC and MIPC) in PM. We also compare the presence of GFP-labelled Pma1 and Cdr1 proteins in PM in confocal microscope's images and Western Blot gels (Figures 2 and 5). compare the presence of GFP-labelled Pma1 and Cdr1 proteins in PM in confocal microscope's images and Western Blot gels (Figures 2 and 5). As in the previous results, we observed the delocalization of both CaPma1p and CaCdr1p from PM to the inside of cells, with temporal differences between the culture phases of the WT strain and strain without ergosterol. It seems that the addition of 0.005 μg/mL AbA did not accelerate the delocalization of CaPma1p and CaCdr1p from PM. Such a shift of the studied proteins was visible in the WT strains only in 14 h of culture. In the case of strains without ergosterol, no increased level of proteins was observed inside the cells in 8 h of culture ( Figure 5).
Interestingly, both CaPma1p and CaCdr1p in the photos from 8 h of culturing were clearly found in PM both in WT and in the strain without ergosterol, while, on the Western Blot, we did not observe the presence of these proteins in 8 h culture in the DRM strain erg11Δ/Δ ( Figure 5 control 8 h, Figure 2B right panel).
In 24 h of culture, we observed a reduced level of CaPma1p in the PM strains WT and erg11Δ/Δ, as well as the lack of CaCdr1p in the PM of these strains ( Figure 5, control 24 h). This result was supported by the data obtained from Western Blot, which confirmed the presence of CaPma1p and CaCdr1p after 24 h of culture. However, the intensity was much lower than that obtained after 14 h of culture (Figure 2). At the same time, in strain erg11Δ/Δ, the level of Cdr1 protein seemed much less than Pma1p on the Western Blot ( Figure 2, panel B).

Lack of Ergosterol as Well as Reduced Sphingolipid Level in PM Reduce Cdr1p and H + -ATPase Activity
We have previously shown that Cdr1p activity in a mutant without ergosterol (KS028) is lower than in the WT strain (CAF2-1) [19]. Here, we investigated how the functioning of CaCdr1p will be affected by the reduced level of sphingolipids (after AbA As in the previous results, we observed the delocalization of both CaPma1p and CaCdr1p from PM to the inside of cells, with temporal differences between the culture phases of the WT strain and strain without ergosterol. It seems that the addition of 0.005 µg/mL AbA did not accelerate the delocalization of CaPma1p and CaCdr1p from PM. Such a shift of the studied proteins was visible in the WT strains only in 14 h of culture. In the case of strains without ergosterol, no increased level of proteins was observed inside the cells in 8 h of culture ( Figure 5).
Interestingly, both CaPma1p and CaCdr1p in the photos from 8 h of culturing were clearly found in PM both in WT and in the strain without ergosterol, while, on the Western Blot, we did not observe the presence of these proteins in 8 h culture in the DRM strain erg11∆/∆ ( Figure 5 control 8 h, Figure 2B right panel).
In 24 h of culture, we observed a reduced level of CaPma1p in the PM strains WT and erg11∆/∆, as well as the lack of CaCdr1p in the PM of these strains ( Figure 5, control 24 h). This result was supported by the data obtained from Western Blot, which confirmed the presence of CaPma1p and CaCdr1p after 24 h of culture. However, the intensity was much lower than that obtained after 14 h of culture (Figure 2). At the same time, in strain erg11∆/∆, the level of Cdr1 protein seemed much less than Pma1p on the Western Blot ( Figure 2, panel B).

Lack of Ergosterol as Well as Reduced Sphingolipid Level in PM Reduce Cdr1p and H + -ATPase Activity
We have previously shown that Cdr1p activity in a mutant without ergosterol (KS028) is lower than in the WT strain (CAF2-1) [19]. Here, we investigated how the functioning of CaCdr1p will be affected by the reduced level of sphingolipids (after AbA treatment) in PM. Firstly, we investigated whether AbA usage contributes to the permeabilization of C. albicans CAF2-1 or KS058 by propidium iodide (PI) staining ( Figure 6). Simultaneously, an R6G efflux assay was used to determine the Cdr1p activity (Figure 7). In the case of the CAF2-1 strain, the addition of AbA caused an increase in fluorescence after 14 and 24 h incubation, which may suggest an increase in Cdr1p activity (Figure 7). We observed progressive permeabilization of PM in the CAF2-1 strain during culturing (Figure 6), especially after 24 h, which may be the cause of rhodamine outflow, not only by Cdr1p, but also partly by PM, which gave increased fluorescence in the tested samples.
After the addition of AbA, we observed a very high permeabilization of PM in strain KS028, as measured by a PI assay ( Figure 6). In turn, we observed a very low fluorescence of rhodamine, which may suggest low Cdr1p activity or the lack thereof (Figure 7). The low activity of Cdr1p in the KS028 strain under the influence of AbA can be confirmed by the observed delocalization of this transporter from PM to the inside of the cell under these conditions ( Figure 5).
In a previous study in the C. albicans strain without ergosterol, we observed both lower Cdr1p and H + -ATPase activity, compared to the CAF2-1 strain [19]. In this work, we investigated the activity of Pma1p after the addition of AbA using the measurement of acidification outside the cells of C. albicans. In almost all samples, we observed a decrease in the intensity of acidification of the environment by cells under the influence of AbA. Only the CAF2-1 strain in the early growth phase (8 h) acidified the environment more intensively in the presence of AbA than without this compound ( Table 1). The inhibition of the rate of acidification of the environment by Pma1p by AbA indicates a decrease in the activity of this protein. The results shown in Figure 5 suggest the additional synthesis of Pma1p, especially by the strain without ergosterol. Despite the delocalization of Pma1 from PM to the inside of cells during the cultivation in the presence of AbA, H + -ATPase is also found in PM. It seems that, after 24 h of culture and in the presence of AbA, in the PM strain without ergosterol, the level of Pma1 protein is higher than in the parental strain ( Figure 5). Hence, the activity of this protein is less inhibited in KS028 than in the CAF2-1 strain (Table 1).
Simultaneously, an R6G efflux assay was used to determine the Cdr1p activity (Figure 7). In the case of the CAF2-1 strain, the addition of AbA caused an increase in fluorescence after 14 and 24 h incubation, which may suggest an increase in Cdr1p activity (Figure 7). We observed progressive permeabilization of PM in the CAF2-1 strain during culturing (Figure 6), especially after 24 h, which may be the cause of rhodamine outflow, not only by Cdr1p, but also partly by PM, which gave increased fluorescence in the tested samples.  After the addition of AbA, we observed a very high permeabilization of PM in strain KS028, as measured by a PI assay ( Figure 6). In turn, we observed a very low fluorescence of rhodamine, which may suggest low Cdr1p activity or the lack thereof (Figure 7). The low activity of Cdr1p in the KS028 strain under the influence of AbA can be confirmed by the observed delocalization of this transporter from PM to the inside of the cell under these conditions ( Figure 5). In a previous study in the C. albicans strain without ergosterol, we observed both lower Cdr1p and H + -ATPase activity, compared to the CAF2-1 strain [19]. In this work, we investigated the activity of Pma1p after the addition of AbA using the measurement of acidification outside the cells of C. albicans. In almost all samples, we observed a decrease in the intensity of acidification of the environment by cells under the influence of AbA. Only the CAF2-1 strain in the early growth phase (8 h) acidified the environment more intensively in the presence of AbA than without this compound ( Table 1). The inhibition of the rate of acidification of the environment by Pma1p by AbA indicates a decrease in the activity of this protein. The results shown in Figure 5 suggest the additional synthesis of Pma1p, especially by the strain without ergosterol. Despite the delocalization of Pma1 from PM to the inside of cells during the cultivation in the presence of AbA, H + -ATPase is also found in PM. It seems that, after 24 h of culture and in the presence of AbA, in the PM strain without ergosterol, the level of Pma1 protein is higher than in the parental strain ( Figure 5). Hence, the activity of this protein is less inhibited in KS028 than in the CAF2-1 strain (Table 1).

Discussion
Localization of membrane proteins in the plasma membrane (PM) microdomains is a suggested mechanism to explain the effect of membrane lipids on fungal virulence [25]. Although lipid nanodomains are still a controversial term, it is increasingly accepted that domains composed of sphingolipids and sterols exist in cell membranes. Much information about lipid microdomains has been obtained in model membrane studies, and only very few studies have focused on lipid microdomains in pathogenic fungi [26]. Kohli et al. [27] used non-pathogenic yeast S. cerevisiae, with an overexpressed CaCdr1p transporter. They found that reduced levels of ergosterol in the membrane cause an increased expression of the CDR1 gene and increased resistance to fluconazole. Pasrija et al. [18] observed that defects in genes encoding the enzymes involved in ergosterol or sphingolipids biosynthesis cause the defective transport of Cdr1p to the S. cerevisiae plasma membrane. According to the above, the non-pathogenic yeast S. cerevisiae seems to be a useful model strain for research. However, according to our results so far, often the processes that take place directly in the pathogenic strain of C. albicans differ from those in S. cerevisiae with the overexpression of pathogen genes, and this is due to differences in metabolism between these microorganisms [28]. We have shown that the CaCdr1 transporter is located in the DRMs of C. albicans. We used the method with cell membrane fractionation in the Optiprep tm gradient and immunoblot analysis. We also developed a new method svFCS to study the localization of CaCdr1p. Using this technique, we proved the living C. albicans cells presence of CaCdr1p in PM microdomains (Figure 1). Thus, we confirmed the results obtained by Pasrija et al. [18] that used S. cerevisiae with CaCdr1p overexpression.
The microdomains in the PM consist of both ergosterol and sphingolipids [12]. If the PM of C. albicans is deprived of ergosterol and sphingolipid levels are reduced, it seems that microdomains will not be created or do not perform their functions properly. In this work, we wanted to observe whether the Cdr1 transporter, as well as H + -ATPase, would be invariably located in the PM, despite the absence of microdomains. The microscopic study of C. albicans Cdr1p-GFP and Pma1p-GFP revealed the delocalization of both proteins from PM to the inside of the cells. In the mutant without ergosterol, proteins delocalization is visible already after 8 h of culture growth, in contrast to WT strains, in which this process was observed only after 14 h ( Figure 5). Unexpectedly, despite the lack of ergosterol and reduced levels of sphingolipids, Cdr1p and Pma1p maintained the localization in PM in 14 h of culture. Moreover, it seems that in 24 h of culture, a certain amount of Pma1p was still present in PM of C. albicans erg11∆/∆ mutant, even after treatment with AbA ( Figure 5). The obtained results suggest that the existence and proper structure of the microdomains are not necessary for maintaining the location of CaCdr1p and CaPma1p in the PM.
Another question was whether CaCdr1p and CaPma1p are located in the PM, despite the lack of ergosterol and reduced sphingolipid levels that are still active. The obtained results showed a decrease in H + -ATPase activity under the influence of AbA, but even in the mutant without ergosterol after 24h of culture with AbA, low activity of this protein was observed (Table 1). It seems that CaCdr1p in the mutant without ergosterol displayed much lower activity than in the WT strain, and the value decreased to zero after 24 h of culture. In cells without ergosterol and with low sphingolipid content, we observed very low or lack of activity of CaCdr1p in the early logarithmic phase of growth (8 h) (Figure 7). In the past, another research team has attempted to answer the question of whether the loss of Cdr1 protein localization in the membrane domain causes a loss of its function and their results seemed to confirm this [28]. The results obtained by our team indicate that the lack of ergosterol and reduced level of SLs allow for the partial persistence of Cdr1p and Pma1p in PM, but reduced the activity of these proteins. It can be concluded that improperly constructed membrane domains interfere with such processes as, for example, the fluidity of membranes. That, in turn, disrupts the molecular interactions of proteins and lipids necessary for PM functioning and activity. Despite observations so far, we are still far away from being able to complete the cognition and description of the molecular environment of proteins in the lipid domains.

Chemicals
Chemicals used in this study were obtained from the following sources: peptone, yeast extract

Strains and Growth Conditions
Strains of C. albicans that were used in this study are listed in Table 2. In all cases, C. albicans strains were grown in YPD agar plates (1% peptone, 1% yeast extract, 2% glucose, and 2% agar) and pre-grown in YPD medium (24 h, 28 • C, 120 rpm). For experiments, 20 mL of YPD medium (with or without AbA) was inoculated with pre-culture, starting at A 600 = 0.1 and grown for 8, 14, or 24 h (28 • C, 120 rpm).

Determination of Minimal Inhibitory Concentration (MIC) and Spot Tests
In order to determine the MIC50 and MIC90 values, a serial dilution of AbA (0-1.6 µg/mL) was prepared in YPD medium using sterile 96-well plates (Sarstedt, Nümbrecht, Germany). Then, wells containing YPD medium were supplemented with AbA and then inoculated with C. albicans CAF2-1 and KS028 strains (final A 600 = 0.01). Plates were incubated overnight at 28 • C. After this, optical density (λ = 600 nm) was measured using Asys UVM 340 (Biogenet). Negative controls were wells with YPD medium alone. The MIC50 and MIC90 values state the lowest concentration of AbA that led to 50% and 90% decreases in C. albicans growth. The experiment was performed in 3 technical (within the same assay) and biological replicates (n = 3).
Spot tests were performed using solid YPD medium containing (or not, in case of control) selected concentrations of AbA. Then, overnight, pre-culture of C. albicans CAF2-1 and KS028 strains were spotted (3 µL) on YPD agar plates in serial dilution, starting from A 600 = 0.7 for both strains. Plates were grown for 48 h at 28 • C, and photographs were taken using FastGene B/G GelPic LED Box (Nippon Genetics Europe GmbH, Düren, Germany).

Sphingolipids Determination
Sphingolipid species were detected in base hydrolyzed lipid samples (Section 4.4) using LC-MS/MS system (n = 3). Extracted lipids were suspended in 500 µL methanol. The UHPLC system (ExionLC Ac, Sciex) was connected to a hybrid triple quadrupole linear ion trap mass spectrometer QTRAP 4500 (Sciex) equipped with a Turbo V source ion spray operating in negative ESI mode. Gradient chromatographic separation was performed on an ZORBAX Eclipse XDB (Agilent, USA) C18 column (50 × 2.1 mm), with a 1.8 µm particle size. The injection volume was 10 µL, and the column was maintained at 37 • C. The mobile phase consisted of water containing 5 mM ammonium formate (eluent A) and methanol containing 5 mM ammonium formate (eluent B), with the flow rate of 500 µL/min. Gradient elution was performed with 70% B for 0.25 min, a linear increase to 100% B until 1 min, 100% B until 7 min, and reequilibration from 7 to 7.1 min, with 70% B, and held to 9 min. The turbo ion spray source was operated in the negative ionization mode using the following settings: ion spray voltage = −4500 V, ion source heater temperature = 600 • C, source gas 1 = 55 psi, source gas 2 = 45 psi, and curtain gas setting = 25 psi. To perform the sphingolipids species survey, an information-dependent acquisition method was prepared. Lipid species were analyzed using negative precursor ion scanning, using m/z 241 and m/z 259 for IPC and m/z 421 for MIPC, respectively, as the precursor ion, and the spectra were obtained over a range from m/z 100 to 1500. Based on the product ion and precursor ion analysis a list of MRM transitions was then generated. The sphingolipids were quantified, in comparison to 08:0 PI (1,2-dioctanoyl-sn-glycero-3-phospho-(1 -myo-inositol) (ammonium salt), Avanti phospholipids, USA).

GC-MS Sterols Analysis in Plasma Membrane
The work-up procedure was previously described [33]. We added to the concentrated lipid extracts (Section 4.4.; n = 3) 0.5 mL CHCl 3 , 0.5 mL MeOH-KOH (0.6 M), and 20 µL cholesterol solution in CHCl 3 (calibration standard, 1 mg/mL). Samples were vortexed and incubated at 23 • C for 1 h. Then, 0.325 mL 1M HCl and 0.125 mL H 2 O were introduced and centrifuged (5000 rcf; 10 • C; 5 min). The lower chloroform layer containing the lipids was transferred to 1.5 mL Eppendorf tubes and dried. Then, 100 µL of silylation reagent BSTFA+TMCS was added and heated for complete silylation at 85 • C for 90 min. The cooled samples had 50 µL hexane introduced and vortexed. Analysis was performed with a gas chromatograph (Agilent 7890) equipped with column HP 5 MS (30 m × 0.25 mm inner diameter, i.d. × 0.25 mm film thickness, f.t.) and 5975C mass detector. The column was maintained at 100 • C for 0.5 min −1 , then increased to 240 • C at a rate of 25 • C min −1 , and finally to 300 • C at a rate of 3 • C min −1 (for 5 min), with helium as a carrier gas at a flow rate of 1 mL·min −1 [33]. The injection port temperature was 250 • C. Sterols were analyzed as trimethylsilyl (TMS) ethers. Ergosterol and lanosterol were analyzed with reference to retention times and fragmentation spectra for standards. Other sterol TMS ethers were identified by comparison with the NIST database or literature data and quantitated using a standard curve for lanosterol.

Determination of Diffusion Time for Cdr1-GFP
For the analysis of diffusion times of Cdr1-GFP protein in C. albicans AsCa1 and KS023, strains were cultured in YPD medium for 24 h (28 • C, 120 rpm). Then, cells were harvested (5 min, 4500 rpm), washed with PBS and subjected to LabTEKtm slides (Thermo Fisher Scientific; Warszawa, Poland). Samples were analysed using spot variation fluorescence correlation spectroscopy (svFCS) microscopy [10]; for each waist, at least 20 cells were measured 20 times. Diffusion time for Cdr1-GFP was calculated using IGOR and DiffusionLawsCIML software.

Isolation of DRMs from C. albicans Cells
DRMs were isolated according to Insenser et al. [34], with modifications. C. albicans strains were cultured for 8, 14, and 24 h in YPD medium; then, approximately OD 600 = 100 of cells were pelleted, washed twice in 0.9% NaCl, and frozen in liquid nitrogen. Cells were resuspended in 500 µL of TNE buffer (50 mM Tris pH 7.5, 150 mM NaCl, 5 mM EDTA), followed by the addition of the same volume of 0.45 mm glass beads. Cells were broken by bead beater, glass beads were removed, and the lysate was cleared by centrifugation (1000 rpm, 3 min, 4 • C). Lysate was transferred to a new tube, with the addition of Triton-X100 to final concentration of 1%, and incubated for 30 min on ice.
The samples were run on SDS-PAGE and analysed by Western Blot. Membranes were visualized using mouse anti-GFP antibodies (for Pma1-GFP protein), 1:3000 in 3% milk in PBST buffer and rabbit anti-Cdr1 antibodies, and 1:1000 in 3% milk in PBST buffer. The experiment is a representative of three independent assays, and the presented conditions were resolved in the same gel and cut out into separate lines.

Microscopic Study of Cdr1-GFP Localization
In order to determine the localization of Cdr1-GFP and Pma1-GFP, C. albicans strains were grown for 8, 14, or 24 h (28 • C, 120 rpm), with or without supplementation with AbA (0.005 µg/mL). Then, cells were centrifuged (3 min, 6 000 rpm), washed 2 times with PBS, and 4 µL of concentrated cell suspension was added on preparation. Microscopic study was performed on a population of cells (at least 100 cells per each case) using a Leica SP8 LSM microscope (Leica microsystems; Wetzlar, Germany). Excitation for GFP-tagged proteins was performed using argon laser (excitation at λ = 488 nm, emission at the range of λ = 500-540 nm).

Propidium Iodide (PI) Staining of C. albicans Cells
In order to investigate the permeabilization of C. albicans PM after AbA treatment, we performed propidium iodide (PI) staining. C. albicans cells after 8, 14, or 24 h of culture, with or without addition of AbA (0.005 µg/mL), were washed three times with PBS (5 min, 4500 rpm) and stained with PI (0.006 mM) for 5 min, RT. Then, cells were harvested, washed three times with PBS, and concentrated. The samples (n = 100 cells per each case) were visualized using a ZEISS AXIO IMAGER A2.

Cdr1p Efflux Pump Assay
The assay was performed as previously described [35] with modifications. C. albicans strains were cultured for 8, 14, or 24 h (YPD, 28 • C, 120 rpm), with or without the addition of AbA (0.005 µg/mL). The cells were harvested by centrifugation (5 min, 4500 rpm), washed twice with sterile distilled water, and once with PBS buffer (pH 7.4). The cells were suspended in fresh PBS buffer to OD 600 of 1.0 and incubated for 60 min at 28 • C and 200 rpm with 5 mM 2-deoxy-D-glucose. Next, 10 µM R6G was added, and the cell suspension was incubated for 90 min. The cells were harvested by centrifugation (5 min, 4500 rpm) and washed with sterile water and PBS buffer (pH 7.4). The pellet was resuspended in PBS buffer to OD 600 of 10.0 and pre-incubated for 5 min at 30 • C, 300 rpm. R6G efflux was initiated by the addition of 2 mM glucose. At specified time intervals (0 and 15 min), 400 µL of cell suspension was transferred to a microcentrifuge tube, and the cells were harvested by centrifugation (10,000× g, 1 min). A total of 100 µL of supernatant was transferred into microtiter black-bottom 96-well plate (Sarstedt, Nümbrecht, Germany). The R6G fluorescence was measured using Cary Eclipse spectrofluorometer (Agilent Technologies, Santa Clara, CA, USA), with excitation at λ = 529 nm (slit 5) and emission at λ = 553 nm (slit 5). The experiment was performed in three biological replicates for each condition.

Statistical Analysis
Statistical analysis of data that were obtain in this study was determined using a Student's t-test (binomial, unpaired) or Tukey HSD post hoc test after the one-way ANOVA (α = 0.05). Data represent the means ± standard errors from at least 3 biological replicates. Microscopic study was performed using 3 biological repetitions (at least 100 cells of each were analyzed) and representative micrographs were presented.

Conclusions
Based on the performed study, we proved that the Cdr1p of C. albicans is localized in the PM microdomains. This conclusion was supported by a novel svFCS technique, which was used for determining the localization of proteins in fungal PM microdomains. The analysis revealed that the absence of ergosterol-sphingolipid microdomains does not exclude the localization of CaCdr1p and CaPma1p in PM. Additionally, the lack of ergosterol and reduced amount of sphingolipids in fungal PM decreases or completely reduces the activity of CaCdr1p and CaPma1p.